TGFB1 and neoplasm: In a mouse triple-negative breast cancer model, dual blockade of CD73 and TGFβ reprograms the tumor microenvironment by reducing MDSCs and M2 macrophages, while increasing activated Tregs, CD8+ T cells, and B cells [61].